搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Rhodococcus erythropolis GTPase obg (obg) CSB-YP508770RLK
CSB-EP508770RLK
CSB-BP508770RLK
CSB-MP508770RLK
CSB-EP508770RLK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus erythropolis ATP synthase epsilon chain (atpC) CSB-YP508771RLK
CSB-EP508771RLK
CSB-BP508771RLK
CSB-MP508771RLK
CSB-EP508771RLK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus erythropolis Glucose-1-phosphate adenylyltransferase (glgC) CSB-YP508772RLK
CSB-EP508772RLK
CSB-BP508772RLK
CSB-MP508772RLK
CSB-EP508772RLK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus erythropolis 50S ribosomal protein L25 (rplY) CSB-YP508773RLK
CSB-EP508773RLK
CSB-BP508773RLK
CSB-MP508773RLK
CSB-EP508773RLK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gemmatimonas aurantiaca Probable inorganic polyphosphate/ATP-NAD kinase (ppnK) CSB-YP508774GFG
CSB-EP508774GFG
CSB-BP508774GFG
CSB-MP508774GFG
CSB-EP508774GFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gemmatimonas aurantiaca Probable nicotinate-nucleotide adenylyltransferase (nadD) CSB-YP508775GFG
CSB-EP508775GFG
CSB-BP508775GFG
CSB-MP508775GFG
CSB-EP508775GFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gemmatimonas aurantiaca 1- (5-phosphoribosyl)-5-[ (5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase CSB-YP508776GFG
CSB-EP508776GFG
CSB-BP508776GFG
CSB-MP508776GFG
CSB-EP508776GFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gemmatimonas aurantiaca Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP508777GFG
CSB-EP508777GFG
CSB-BP508777GFG
CSB-MP508777GFG
CSB-EP508777GFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gemmatimonas aurantiaca 30S ribosomal protein S12 (rpsL) CSB-YP508778GFG
CSB-EP508778GFG
CSB-BP508778GFG
CSB-MP508778GFG
CSB-EP508778GFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gemmatimonas aurantiaca 50S ribosomal protein L16 (rplP) CSB-YP508779GFG
CSB-EP508779GFG
CSB-BP508779GFG
CSB-MP508779GFG
CSB-EP508779GFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gemmatimonas aurantiaca 50S ribosomal protein L9 (rplI) CSB-YP508780GFG
CSB-EP508780GFG
CSB-BP508780GFG
CSB-MP508780GFG
CSB-EP508780GFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gemmatimonas aurantiaca Aspartate carbamoyltransferase (pyrB) CSB-YP508781GFG
CSB-EP508781GFG
CSB-BP508781GFG
CSB-MP508781GFG
CSB-EP508781GFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gemmatimonas aurantiaca 60 kDa chaperonin (groL), partial CSB-YP508782GFG
CSB-EP508782GFG
CSB-BP508782GFG
CSB-MP508782GFG
CSB-EP508782GFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gemmatimonas aurantiaca UvrABC system protein C (uvrC), partial CSB-YP508783GFG
CSB-EP508783GFG
CSB-BP508783GFG
CSB-MP508783GFG
CSB-EP508783GFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gemmatimonas aurantiaca 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (ispF) CSB-YP508784GFG
CSB-EP508784GFG
CSB-BP508784GFG
CSB-MP508784GFG
CSB-EP508784GFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gemmatimonas aurantiaca 50S ribosomal protein L27 (rpmA) CSB-YP508785GFG
CSB-EP508785GFG
CSB-BP508785GFG
CSB-MP508785GFG
CSB-EP508785GFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gemmatimonas aurantiaca Ribonuclease Z (rnz) CSB-YP508786GFG
CSB-EP508786GFG
CSB-BP508786GFG
CSB-MP508786GFG
CSB-EP508786GFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gemmatimonas aurantiaca UPF0061 protein GAU_3822 (GAU_3822), partial CSB-YP508787GFG
CSB-EP508787GFG
CSB-BP508787GFG
CSB-MP508787GFG
CSB-EP508787GFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium bovis Holo-[acyl-carrier-protein] synthase (acpS) CSB-YP508788MVI
CSB-EP508788MVI
CSB-BP508788MVI
CSB-MP508788MVI
CSB-EP508788MVI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium bovis Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP508789MVI
CSB-EP508789MVI
CSB-BP508789MVI
CSB-MP508789MVI
CSB-EP508789MVI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>